Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Ohar

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 25, 2019
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow RateDonald A Mahler, Jill A Ohar, Chris N Barnes, et al.
Canadian Respiratory Journal|April 1, 2024
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory FlowJill A Ohar, Donald A Mahler, Gabrielle N Davis, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 31, 2018
Spirometry in Hospitalized Patients with Acute Exacerbation of COPD Accurately Predicts Post Discharge Airflow ObstructionChee H Loh, Frank A Genese, Kavya K Kannan, et al.
Human Molecular Genetics|May 19, 2021
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumorsMitchell Cheung, Yuwaraj Kadariya, Eleonora Sementino, et al.
North American Journal of Medical Sciences|May 25, 2012
Health-related quality of life and chronic obstructive pulmonary disease in North CarolinaDavid W Brown, Roy Pleasants, Jill A Ohar, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 7, 2025
Improving Research for COPD in Rural Areas: A Statement from the COPD Foundation Medical and Scientific Advisory CommitteeMaura E Thornton, David M Mannino, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 6, 2022
Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort StudyBrendan Clark, Brian J Wells, Amit K Saha, et al.
Respiratory Research|March 17, 2009
Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokersAlireza Sadeghnejad, Jill A Ohar, Siqun L Zheng, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel ConsensusRobert A Wise, Russell A Acevedo, Antonio R Anzueto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2016
Gender and asthma-chronic obstructive pulmonary disease overlap syndromeAnne G Wheaton, Roy A Pleasants, Janet B Croft, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 25, 2019
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow RateDonald A Mahler, Jill A Ohar, Chris N Barnes, et al.
Canadian Respiratory Journal|April 1, 2024
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory FlowJill A Ohar, Donald A Mahler, Gabrielle N Davis, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 31, 2018
Spirometry in Hospitalized Patients with Acute Exacerbation of COPD Accurately Predicts Post Discharge Airflow ObstructionChee H Loh, Frank A Genese, Kavya K Kannan, et al.
Human Molecular Genetics|May 19, 2021
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumorsMitchell Cheung, Yuwaraj Kadariya, Eleonora Sementino, et al.
North American Journal of Medical Sciences|May 25, 2012
Health-related quality of life and chronic obstructive pulmonary disease in North CarolinaDavid W Brown, Roy Pleasants, Jill A Ohar, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 7, 2025
Improving Research for COPD in Rural Areas: A Statement from the COPD Foundation Medical and Scientific Advisory CommitteeMaura E Thornton, David M Mannino, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 6, 2022
Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort StudyBrendan Clark, Brian J Wells, Amit K Saha, et al.
Respiratory Research|March 17, 2009
Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokersAlireza Sadeghnejad, Jill A Ohar, Siqun L Zheng, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel ConsensusRobert A Wise, Russell A Acevedo, Antonio R Anzueto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2016
Gender and asthma-chronic obstructive pulmonary disease overlap syndromeAnne G Wheaton, Roy A Pleasants, Janet B Croft, et al.
Pageof 6